Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Intarcia Therapeutics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10283
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that focuses on the development of therapies through its proprietary Medici Drug Delivery System, a subcutaneous delivery system to treat chronic conditions. The company’s product candidate includes ITCA 650, intended for the treatment of type II diabetes. It also carries out pipeline products in various therapeutic areas, including autoimmune diseases, obesity, HIV and other serious disorders. The company has manufacturing facility in Hayward, California; and research and development facility in Durham, North Carolina. Intarcia is headquartered in Boston, Massachusetts, the US.

Intarcia Therapeutics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intarcia Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intarcia Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Intarcia Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intarcia Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Intarcia Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Intarcia Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Intarcia Therapeutics Raises US$200 Million In Venture Financing 10
Intarcia Therapeutics Raises US$210 Million In Venture Financing 12
Intarcia Therapeutics Raises USD0.7 Million in Venture Financing 14
Intarcia Therapeutics Raises Additional US$5.5 Million In Venture financing 15
Intarcia Therapeutics Plans To License Drug-Formulation Technology 16
Equity Offering 17
Intarcia Therapeutics Raises USD215 Million in First Tranche of Private Placement of Shares 17
Intarcia Therapeutics Inc – Key Competitors 18
Intarcia Therapeutics Inc – Key Employees 19
Intarcia Therapeutics Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Intarcia Therapeutics Inc, Medical Equipment, Key Facts 2
Intarcia Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intarcia Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Intarcia Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intarcia Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Intarcia Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Intarcia Therapeutics Raises US$200 Million In Venture Financing 10
Intarcia Therapeutics Raises US$210 Million In Venture Financing 12
Intarcia Therapeutics Raises USD0.7 Million in Venture Financing 14
Intarcia Therapeutics Raises Additional US$5.5 Million In Venture financing 15
Intarcia Therapeutics Plans To License Drug-Formulation Technology 16
Intarcia Therapeutics Raises USD215 Million in First Tranche of Private Placement of Shares 17
Intarcia Therapeutics Inc, Key Competitors 18
Intarcia Therapeutics Inc, Key Employees 19
Intarcia Therapeutics Inc, Other Locations 20
Intarcia Therapeutics Inc, Subsidiaries 20

List of Figures
Intarcia Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Intarcia Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intarcia Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Intarcia Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intarcia Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verizon Communications Inc.:企業の戦略・SWOT・財務情報
    Verizon Communications Inc. - Strategy, SWOT and Corporate Finance Report Summary Verizon Communications Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Artizian Catering Services Limited:企業の戦略・SWOT・財務情報
    Artizian Catering Services Limited - Strategy, SWOT and Corporate Finance Report Summary Artizian Catering Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • State Street Corporation:企業のM&A・事業提携・投資動向
    State Street Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's State Street Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • ICICI Bank Ltd:企業の戦略・SWOT・財務情報
    ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Baoviet Holdings:企業の戦略・SWOT・財務分析
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Arise AB (ARISE):企業の財務・戦略的SWOT分析
    Arise AB (ARISE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CeQur SA:医療機器:M&Aディール及び事業提携情報
    Summary CeQur SA (CeQur) is a medical device company that develops and commercializes insulin delivery systems. The company offers product PAQ, a wearable insulin delivery device, which delivers both basal and bolus doses. Its PAQ product consist two components such as insulin reservoir and messenge …
  • Gridsum Holding, Inc. (GSUM):企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Miltenyi Biotec GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company offers sample preparation, cell separation, flow cytometry, cell culture and stimulati …
  • Singapore Press Holdings Ltd (T39):企業の財務・戦略的SWOT分析
    Singapore Press Holdings Ltd (T39) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Unilever Pakistan Limited:企業の戦略・SWOT・財務分析
    Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report Summary Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Mohammad Al-Mojil Group:企業の戦略・SWOT・財務情報
    Mohammad Al-Mojil Group - Strategy, SWOT and Corporate Finance Report Summary Mohammad Al-Mojil Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Saudi Arabian Mining Co:戦略・SWOT・企業財務分析
    Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report Summary Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Xinjiang Goldwind Science & Technology Co Ltd (002202):企業の財務・戦略的SWOT分析
    Xinjiang Goldwind Science & Technology Co Ltd (002202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • ReNeuron Group Plc (RENE):企業の財務・戦略的SWOT分析
    ReNeuron Group Plc (RENE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Abbott Diabetes Care Inc:製品パイプライン分析
    Summary Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company’s products include glucose monitor …
  • Kineta Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • ReproCELL Inc (4978):製薬・医療:M&Aディール及び事業提携情報
    Summary ReproCELL Inc (ReproCELL) is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation materials, and cell and biorepository. Its research reagent products include hES iPSC culture reagents …
  • Grasim Industries Ltd (GRASIM):企業の財務・戦略的SWOT分析
    Grasim Industries Ltd (GRASIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Greensmith Energy Management Systems LLC-エネルギー分野:企業M&A・提携分析
    Summary Greensmith Energy Management Systems, LLC (Greensmith) is a provider of energy storage management and services. The company specializes in software and control solutions to operate and manage Distributed Energy Storage Systems (DESS) for utility-scale, C&I or Micro-grid deployments. It offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆